Through the activation of the RAS-RAF-MEK-ERK and Wnt/β-catenin signaling pathways, elevated osteonectin expression in TIME of iCCA correlates significantly with tumor size, local and distant invasion, and advanced cancer stages [116,117]. The gene discussed is SPARC; the disease is neoplasm.